C4 Therapeutics, Inc.(CCCC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CCCC C4 Therapeutics, Inc.

休市中 04-24 16:00:00 EDT

2.88

-0.09

-3.03%

盘后2.81

-0.07-2.26%

19:50 EDT

最高3.01	最低2.77	成交量214.28万
今开2.97	昨收2.97	日振幅8.08%
总市值2.81亿	流通市值2.08亿	总股本9,758万
成交额608.14万	换手率2.97%	流通股本7,205万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CCCC","market":"US","secType":"STK","nameCN":"C4 Therapeutics, Inc.","latestPrice":2.88,"timestamp":1777060800000,"preClose":2.97,"halted":0,"volume":2142818,"hourTrading":{"tag":"盘后","latestPrice":2.8149,"preClose":2.88,"latestTime":"19:50 EDT","volume":21608,"amount":62217.2975,"timestamp":1777074639581,"change":-0.0651,"changeRate":-0.022604,"amplitude":0.023924},"delay":0,"changeRate":-0.0303030303030304,"floatShares":72053500,"shares":97578175,"eps":-1.266598,"marketStatus":"休市中","change":-0.09,"latestTime":"04-24 16:00:00 EDT","open":2.965,"high":3.01,"low":2.77,"amount":6081372.3401408,"amplitude":0.080808,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.266598,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777276800000},"marketStatusCode":7,"adr":0,"listingDate":1601611200000,"exchange":"NASDAQ","adjPreClose":2.97,"preHourTrading":{"tag":"盘前","latestPrice":2.98,"preClose":2.97,"latestTime":"09:29 EDT","volume":24500,"amount":73270.7829,"timestamp":1777037399999,"change":0.01,"changeRate":0.003367,"amplitude":0.03367},"postHourTrading":{"tag":"盘后","latestPrice":2.8149,"preClose":2.88,"latestTime":"19:50 EDT","volume":21608,"amount":62217.2975,"timestamp":1777074639581,"change":-0.0651,"changeRate":-0.022604,"amplitude":0.023924},"volumeRatio":0.9806501828848039,"impliedVol":1.1351,"impliedVolPercentile":0.4622},"requestUrl":"/m/hq/s/CCCC","defaultTab":"news","newsList":[{"id":"2626213871","title":"C4 Therapeutics与罗氏扩大合作，达成逾10亿美元新癌症药物协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2626213871","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626213871?lang=zh_cn&edition=full","pubTime":"2026-04-09 22:01","pubTimestamp":1775743260,"startTime":"0","endTime":"0","summary":"C4 Therapeutics周四宣布，已与瑞士制药巨头罗氏签署一项新的合作协议，共同研发新型癌症药物，交易总价值有望超过10亿美元。　　此次合作将聚焦于一种新兴的癌症疗法——降解剂-抗体偶联物。　　C4 Therapeutics：利用其专有的TORPEDO平台设计具有payload特性的降解剂候选分子。　　C4 Therapeutics将获得2000万美元的预付款。罗氏业务发展全球负责人Boris Zatra表示：“我们与C4 Therapeutics的关系建立在十年的信任和共同的科学追求之上”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-09/doc-inhtxkar8629046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4007","CCCC","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108241653","title":"C4 Therapeutics与罗氏深化长期合作 签署新型降解剂-抗体偶联物研发协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1108241653","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108241653?lang=zh_cn&edition=full","pubTime":"2026-04-09 19:00","pubTimestamp":1775732419,"startTime":"0","endTime":"0","summary":"C4 Therapeutics宣布与罗氏集团达成战略拓展协议，双方将基于新型靶向蛋白降解技术平台，共同探索降解剂-抗体偶联物的开发路径。该合作标志着两家公司在肿瘤治疗领域长达数年的合作关系进入新阶段。根据协议框架，C4 Therapeutics将获得预付款及阶段性研发里程碑资金，具体金额未公开。降解剂-抗体偶联物技术有望通过抗体介导的靶向递送系统，提升蛋白降解剂在病变组织的富集效率。此次合作延续了双方自2020年以来的联合研发成果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CCCC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158023539","title":"C4 Therapeutics启动Cemsidomide联合Elranatamab治疗复发/难治性多发性骨髓瘤的1B期临床试验首位患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1158023539","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158023539?lang=zh_cn&edition=full","pubTime":"2026-03-25 19:02","pubTimestamp":1774436533,"startTime":"0","endTime":"0","summary":"C4 Therapeutics, Inc.宣布，其针对复发/难治性多发性骨髓瘤的1B期临床试验已完成首位患者给药。该试验旨在评估Cemsidomide与Elranatamab（商品名：Elrexfio®）联合疗法的安全性与有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CCCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152815912","title":"C4 Therapeutics启动Cemsidomide联合地塞米松治疗复发/难治性多发性骨髓瘤的II期Momentum试验首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1152815912","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152815912?lang=zh_cn&edition=full","pubTime":"2026-02-23 20:01","pubTimestamp":1771848077,"startTime":"0","endTime":"0","summary":"C4 Therapeutics公司宣布，其口服IKZF1/3降解剂Cemsidomide联合地塞米松治疗复发/难治性多发性骨髓瘤的II期Momentum临床试验已完成首例患者给药。这一进展标志着该创新疗法在临床开发中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CCCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177745828","title":"C4 Therapeutics第三季度每股收益为-0.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177745828","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177745828?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:56","pubTimestamp":1763571373,"startTime":"0","endTime":"0","summary":"11月6日 - C4 Therapeutics第三季度营收为1120万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CCCC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582392495","title":"C4 Therapeutics, Inc.盘中异动 下午盘急速上涨5.13%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582392495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582392495?lang=zh_cn&edition=full","pubTime":"2025-11-12 04:09","pubTimestamp":1762891751,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日04时09分，C4 Therapeutics, Inc.股票出现波动，股价快速拉升5.13%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.79%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家临床阶段的生物制药公司，致力于实现靶向蛋白质降解科学的承诺，创造新一代药物，改变患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111204091194fe3ffa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111204091194fe3ffa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","BK4007","CCCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138004608","title":"C4 Therapeutics预计现有现金、现金等价物及可售证券将支持公司运营计划至2028年底","url":"https://stock-news.laohu8.com/highlight/detail?id=1138004608","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138004608?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:22","pubTimestamp":1762431771,"startTime":"0","endTime":"0","summary":"C4 Therapeutics预计现有的现金、现金等价物及可售证券将使公司能够继续执行其运营计划，直至2028年底。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CCCC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152011940","title":"C4 Therapeutics 第三季度每股收益为 -0.44 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152011940","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152011940?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:17","pubTimestamp":1762431463,"startTime":"0","endTime":"0","summary":"11月6日 - C4 Therapeutics 第三季度的收入为 1120 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CCCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518276177","title":"C4 Therapeutics, Inc.盘中异动 股价大跌5.08%报2.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518276177?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:10","pubTimestamp":1741615807,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时10分，C4 Therapeutics, Inc.股票出现波动，股价大幅下挫5.08%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3220.76%、698.32%、113.46%，振幅较大的相关个股有Scisparc Ltd.、Pmgc Holdings Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、32.14%、30.70%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221007abf30ae2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310221007abf30ae2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CCCC","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517943743","title":"C4 Therapeutics, Inc.2024财年实现净利润-1.05亿美元，同比增加20.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517943743?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363236,"startTime":"0","endTime":"0","summary":"3月8日，C4 Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-1.05亿美元，同比增加20.45%；其中营业收入为35.58百万美元，同比增加71.39%，每股基本收益为-1.52美元。从资产负债表来看，C4 Therapeutics, Inc.总负债1.34亿美元，其中短期债务5.77百万美元，资产负债比为2.62，流动比率为0.06。机构评级：截至2025年3月8日，当前有8家机构对C4 Therapeutics, Inc.目标价做出预测，其中目标均价为15.56美元，其中最低目标价为3.00美元，最高目标价为50.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000047abed65e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000047abed65e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CCCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516634998","title":"C4 Therapeutics, Inc.盘中异动 股价大跌5.08%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634998?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012296,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，C4 Therapeutics, Inc.股票出现异动，股价快速跳水5.08%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Aeon Biopharma, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为46.98%、22.45%、21.63%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Akari Therapeutics Plc、Aim Immunotech Inc.，振幅分别为9.35%、6.78%、6.67%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032231369637abd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032231369637abd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CCCC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514238389","title":"C4 Therapeutics, Inc.盘中异动 早盘股价大涨5.28%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514238389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514238389?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:12","pubTimestamp":1740669153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时12分，C4 Therapeutics, Inc.股票出现波动，股价大幅拉升5.28%。截至发稿，该股报2.79美元/股，成交量8.1413万股，换手率0.12%，振幅6.79%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272312339632ba59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272312339632ba59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CCCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514886236","title":"C4 Therapeutics, Inc.盘中异动 股价大跌5.02%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514886236?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:16","pubTimestamp":1740600964,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时16分，C4 Therapeutics, Inc.股票出现异动，股价快速跳水5.02%。截至发稿，该股报2.65美元/股，成交量51.8944万股，换手率0.74%，振幅6.28%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227041604abde381e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227041604abde381e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CCCC","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514168440","title":"C4 Therapeutics, Inc.盘中异动 早盘大幅跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514168440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514168440?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:19","pubTimestamp":1740496795,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时19分，C4 Therapeutics, Inc.股票出现异动，股价大幅下挫5.19%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231955abdc8a93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231955abdc8a93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CCCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512993721","title":"C4 Therapeutics, Inc.盘中异动 下午盘急速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512993721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512993721?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:14","pubTimestamp":1739906065,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时14分，C4 Therapeutics, Inc.股票出现异动，股价急速下跌5.03%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为839.93%、208.49%、168.22%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031425a24ae70f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219031425a24ae70f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CCCC","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510860361","title":"C4 Therapeutics, Inc.盘中异动 急速下挫5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510860361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510860361?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:04","pubTimestamp":1739207046,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时04分，C4 Therapeutics, Inc.股票出现波动，股价急速跳水5.21%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010406a240c1f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211010406a240c1f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CCCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509337602","title":"C4 Therapeutics, Inc.盘中异动 快速上涨5.00%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509337602","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509337602?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:58","pubTimestamp":1738771100,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时58分，C4 Therapeutics, Inc.股票出现异动，股价快速上涨5.00%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4196.01%、1381.89%、1268.84%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为94.64%、59.80%、54.05%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205235820987b8bce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205235820987b8bce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CCCC","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508734141","title":"C4 Therapeutics, Inc.盘中异动 早盘大幅下挫5.76%报3.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508734141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508734141?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:33","pubTimestamp":1738593239,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时33分，C4 Therapeutics, Inc.股票出现异动，股价急速跳水5.76%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为345.21%、277.89%、132.59%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为57.23%、33.33%、26.50%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322335998796f6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322335998796f6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CCCC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507467088","title":"C4 Therapeutics, Inc.盘中异动 快速拉升5.01%报3.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507467088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507467088?lang=zh_cn&edition=full","pubTime":"2025-01-31 04:08","pubTimestamp":1738267719,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日04时08分，C4 Therapeutics, Inc.股票出现异动，股价急速拉升5.01%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131040839abbd85e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131040839abbd85e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CCCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503706647","title":"C4 Therapeutics, Inc.盘中异动 急速拉升6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503706647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503706647?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951549,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，C4 Therapeutics, Inc.股票出现波动，股价急速上涨6.95%。C4 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.07%、54.43%、35.46%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Eterna Therapeutics Inc.，振幅分别为14.29%、12.00%、11.55%。C4 Therapeutics, Inc.公司简介：C4 Therapeutics Inc 是一家生物制药公司，致力于推进靶向蛋白质降解科学，开发新一代小分子药物，以改变疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522323098673b6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522323098673b6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CCCC","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.c4therapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0706},{"period":"3month","weight":0.3395},{"period":"6month","weight":0.1755},{"period":"1year","weight":0.7888},{"period":"ytd","weight":0.5079}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"C4 Therapeutics, Inc.于2015年10月7日在特拉华州注册成立。该公司是一家生物制药公司，致力于利用人体对蛋白质水平的自然调节作用，开发新的治疗性候选药物，以靶向和破坏引起疾病的蛋白质来治疗癌症，神经退行性疾病和其他疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.036957},{"month":2,"riseRate":0.5,"avgChangeRate":0.126939},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.192032},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.149826},{"month":5,"riseRate":0.4,"avgChangeRate":-0.071636},{"month":6,"riseRate":0.6,"avgChangeRate":-0.011627},{"month":7,"riseRate":1,"avgChangeRate":0.343381},{"month":8,"riseRate":0.4,"avgChangeRate":-0.01341},{"month":9,"riseRate":0.2,"avgChangeRate":-0.123891},{"month":10,"riseRate":0.4,"avgChangeRate":0.000588},{"month":11,"riseRate":0.5,"avgChangeRate":0.01571},{"month":12,"riseRate":0.166667,"avgChangeRate":0.247814}],"exchange":"NASDAQ","name":"C4 Therapeutics, Inc.","nameEN":"C4 Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"C4 Therapeutics, Inc.(CCCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供C4 Therapeutics, Inc.(CCCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"C4 Therapeutics, Inc.,CCCC,C4 Therapeutics, Inc.股票,C4 Therapeutics, Inc.股票老虎,C4 Therapeutics, Inc.股票老虎国际,C4 Therapeutics, Inc.行情,C4 Therapeutics, Inc.股票行情,C4 Therapeutics, Inc.股价,C4 Therapeutics, Inc.股市,C4 Therapeutics, Inc.股票价格,C4 Therapeutics, Inc.股票交易,C4 Therapeutics, Inc.股票购买,C4 Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"C4 Therapeutics, Inc.(CCCC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供C4 Therapeutics, Inc.(CCCC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}